Fostering Africa's Growth In Vaccine Manufacturing With A Billion-Dollar Investment
Pharmaceuticals / Africa / Tue 12 Dec, 2023
Key View
- The AVMA will significantly boost Africa's self-supply of vaccines in the long-term.
- The AVMA will enhance pandemic preparedness and address life-threatening diseases in the region.
- The approval of the AVMA, alongside trade harmonisation will transform the pharmaceutical landscape.
The African Vaccine Manufacturing Accelerator